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Abstract
Objectives
Hemangioblastoma refers to a benign vascular neoplasm that 
comprises stromal and capillary cells. Based on the classification of 
nervous system tumors proposed by WHO, hemangioblastomas are 
classified as Grade I meningeal tumors of uncertain origin. These 
tumors are found almost exclusively in the central nervous system 
(CNS) and account for 0.9% to 2.1% of all primary CNS tumors.
Materials & Methods
In this descriptive retrospective study, the archives of pathology 
reports were reviewed in the Department of Pathology of Shohada-
e-Tajrish Hospital, Tehran, Iran and patients with definite diagnosis 
of hemangioblastoma made through histopathological examinations 
during 2004-2014 were identified. Age, gender and the location of 
tumor were extracted from the medical records and entered into 
SPSS statistical software v.22 for analysis. 
Results
Thirty patients including 16 males (53.3%) and 14 females (46.7%) were 
identified. The mean age of the patients was calculated to be 41.2±13.47 
yr, ranging from 19 to 62 yr old. The majority of lesions had been found 
in the cerebellum of the patients (93.3%); only one had occurred in the 
cerebrum (3.3%) and another in the fourth ventricle (3.3%). 
Conclusion
Cerebellum is the most commonly affected location in patients with 
CNS hemangioblastomas, and a male preponderance is observed in 
these cases. 
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Introduction
Hemangioblastoma refers to a benign vascular 
neoplasm that comprises stromal and capillary cells 
(1). Based on the classification of nervous system 
tumors proposed by the WHO, hemangioblastomas 
are classified as Grade I meningeal tumors of 
uncertain origin (2, 3). These tumors are found 
almost exclusively in the central nervous system 
(CNS) and rarely occur in the peripheral nervous 
system. They can occur sporadically in 60%-
75% of cases or in association with von Hippel-
Lindau (VHL) disease in 20%-40% of cases (4, 
5). Sporadic lesions have a later onset (40-50 yr) 
compared to VHL-associated tumors (30-40 yr) (6). 
Hemangioblastomas account for 0.9% to 2.1% of all 
primary CNS tumors and most commonly affect the 
cerebellum (63%), followed by spinal cord (32%) 
(7, 8) and medulla (5%) (9). The tumor has also 
been rarely reported in other locations including 
supratentorial compartment (10-12), sella turcica 
(13), optic nerve (14, 15), ventricular system (16, 
17) peripheral nerves (18, 19) or soft tissues (20). 
Males are 1.5 to 2 times more frequently affected 
by hemangioblastomas compared to females. 
On neuroimaging studies, the lesions appear as 
either small contrast-enhancing mural nodules with 
associated pseudocysts in 30% to 80% of cases, 
or solid tumors (21). The clinical presentation of 
hemangioblastoma is caused by the mass effect 
of the tumor or impairment of cerebrospinal 
fluid and depends on the anatomical location and 
growth pattern of the lesion (22-24). Generally, 
intracranial lesions present with a long history 
of minor neurological symptoms followed by an 
abrupt exacerbation. Ataxia, discoordination or 
increased intracranial pressure can be seen in 
cerebellar hemangioblastomas and spinal cord 
lesions can be associated with pain and signs of 
spinal cord compression. 
Considering the low incidence of hemangioblastoma 
and the consequent lack of information on this 
entity particularly in Iran, hereby we present basic 
demographic characteristics of hemangioblastoma 
tumors diagnosed in the patients referring to 
Shohada-e-Tajrish Hospital, Tehran, Iran during 
2004-2014. 
Materials & Methods
In this descriptive retrospective study, the archives 
of pathology reports were reviewed in the 
Department of Pathology of Shohada-e-Tajrish 
Hospital and patients with definite diagnosis of 
hemangioblastoma made through histopathological 
examinations during 2004-2014 were identified. 
Age, gender and the location of tumor were extracted 
from the medical records and entered into SPSS 
statistical software v.22 (25) for analysis.
The study was approved by Ethics Committee of 
the hospital.  
Results
Thirty patients including 16 males (53.3%) and 14 
females (46.7%) were identified. The mean age of the 
patients was calculated to be 41.2±13.47 yr, ranging 
from 19 to 62 yr old. The mean age of male subjects 
was slightly higher than that of females (41.75 vs. 
40.57 yr). The majority of lesions had been found in 
the cerebellum of the patients (93.3%); only one had 
occurred in the cerebrum (3.3%) and another in the 
fourth ventricle (3.3%) (Table 1). Overall, 28 lesions 
found in the cerebellum, 3 (10.0%) were reported in 
the right hemisphere, 7 (23.3%) in the left hemisphere 
and the remaining 18 (60.0%) were just reported to 
be in the cerebellum and their exact location was not 
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recorded. Table 2 presents age- gender and site-wise 
Table 1. Demographic characteristics of the patients
Age (yr) 41.2±13.47
Gender Male 16 (53.3%)
Female 14 (46.7%)
Site Cerebellum (Side not specified) 18 (60.0%)
Cerebellum (Right hemisphere) 3 (10.0%)
Cerebellum (Left hemisphere) 7 (23.3%)
Fourth ventricle 1 (3.3%)
Cerebrum 1 (3.3%)
Table 2. Age-gender- and site-wise distribution of hemangioblastoma cases
 Year Age(yr) Gender Site
2004 52 Female Cerebellum
2005 59 Female Cerebellum
62 Female Cerebellum
2006 50 Male Cerebellum (Right hemisphere)
48 Male Cerebellum (Left hemisphere)
62 Female Cerebellum (Left hemisphere)
2007 23 Male Cerebellum
31 Male Cerebellum
19 Female Fourth ventricle
28 Female Cerebellum (Right hemisphere)
2008 49 Male Cerebellum
24 Female Cerebellum
53 Female Cerebellum
2009 48 Male Cerebellum
61 Male Cerebellum
23 Male Cerebellum
38 Female Cerebellum (Left hemisphere)
20 Female Cerebellum
39 Female Cerebellum
41 Female Cerebellum (Left hemisphere)
27 Female Cerebellum
2010 45 Male Cerebellum
34 Male Cerebellum
2011 42 Male Cerebellum (Right hemisphere)
27 Male Cerebellum (Left hemisphere)
2012 43 Male Cerebellum (Left hemisphere)
58 Male Cerebellum
32 Male Cerebrum
2013 44 Female Cerebellum (Left hemisphere)
2014 54 Male Cerebellum
distribution of the 30 cases included in this study. 
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Discussion
Overall, 30 patients with definite diagnosis of 
hemangioblastoma were identified in the pathology 
archives of Shohada-e-Tajrish Hospital. The mean 
age of the patients was found to be 41.2±13.47 
yr, ranging from 19 to 62 yr old, which was quite 
compatible with the results of previous reports (4, 
6, 7, 26, 27). Cerebellum was the most commonly 
affected location by the tumors accounting for 
93.3% of cases. This figure was slightly higher 
than the reports of previous studies. Overall, 63% 
of cerebellum involvement was reported in patients 
with CNS hemangioblastomas (6). The second most 
common affected site has been reported by multiple 
studies to be the spinal cord (2, 4, 6, 23, 27) while 
none of the cases included in our study had tumors 
of this location. Instead the two sites affected by 
hemangioblastomas other than cerebellum were 
found to be cerebrum in one patient and the fourth 
ventricle in another. A male preponderance was 
observed in the present case series with a ratio of 
1.14. Some of the previous studies had shown equal 
risk in both genders (28) while other surveys have 
reported the same male preponderance as found in 
the present study (4, 6, 7, 29).
Hemangioblastomas are adherent to the pia mater 
and have a well-defined border. They usually 
are bright red or red-orange due to the extreme 
vascularity from the pial vessels (30). The tumor 
consists of yellow areas of the lipid-laden stromal 
cells with a spongy and hemorrhagic cut surface. 
The majority of its vascular components consists 
comprise small capillaries that may lead to larger 
vessels. The lesion might also have peritumoral 
cysts fluid filled and surrounded by Rosenthal 
fibers and reactive gliosis (6). 
As highly vascular tumors, hemangioblastomas can 
consist of variable proportions of capillary-sized 
thin walled vessels interweaved with pericytes and 
inhibin-expressing, round or polygonal, vacuolated 
stromal cells of uncertain origin (31). These stromal 
cells are lightly periodic acid-Schiff (PAS) positive 
and have a lipid-rich, pale eosinophilic cytoplasm. 
The nuclei of these cells are round or oval and 
centrally located and might show considerable 
pleomorphism such as karyomegaly, irregularities 
of the nuclear membrane and hyperchromasia. 
Specific organelles or intracellular attachments 
might lack in these stromal cells but various 
lipid droplets and glycogen particles might be 
found in their cytoplasm (32). Weibel-Palade-like 
bodies and neurosecretory granule-like structures 
have also been described by some studies. 
Uncommonly, mitotic figures do not affect the 
clinical characteristics of the lesion. A second 
somatic mutation of the VHL allele is present in 
these stromal cells and so they are considered as the 
neoplastic element in hemangioblastomas. In the 
reticular variant of the lesion, vascular components 
are predominant while the stromal components 
predominate in the cellular variant (6). 
The treatment of choice for hemangioblastomas is 
surgical excision and radiotherapy is reserved for 
non-resectable or recurrent lesions (33). Tumor 
regrowth might be associated with solid lesions and 
paucity of stromal cells within the tumor (34). VHL 
disease has been shown to be accompanied by an 
increased risk for multifocal hemangioblastomas 
and extracerebellar lesion (9). 
In conclusion, cerebellum is the most commonly 
affected location in patients with CNS 
hemangioblastomas, and a male preponderance is 
observed in these cases.  
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